Investment Memo

Date:24.04.2026Company:NUTRITRACKSector:HealthTech / NutritionStage:SeedJurisdiction:Netherlands

Company overview

NutriTrack is a digital nutrition platform combining a consumer app with a clinician dashboard to help dietitians, clinics, and insurers manage patient nutrition through AI-assisted food logging and connected health data. The company operates in clinical nutrition and chronic-disease management, and enables patients with diabetes, obesity, and cardiovascular risk to track intake automatically while their care teams monitor adherence in real time.

Transaction overview

Target Raise: €1,500,000

Offered Stake: 15%

Instrument: Equity

Implied Valuation: €10,000,000

Use of Funds

Use of funds breakdown
40%Product & Engineering
30%Go-to-market & sales
20%Data/ML infrastructure & tooling
10%General and administrative

Team

Team Score: 4 / 5

FOUNDER

Sanne de Vries

CEO & Founder

Registered dietitian turned product builder with 9 years across clinical nutrition and digital health. Previously led product at a Dutch telehealth scale-up before founding NutriTrack.

advisor

Dr. Pieter Janssen

Medical & Clinical Advisor

Practicing endocrinologist and former head of a hospital nutrition unit. Advises on clinical validation, reimbursement strategy, and medical-device regulatory pathways across the EU.

Core team

Eva Bakker

Chief Product Officer

Product leader specializing in patient-facing health apps and behavior-change design. Previously shipped consumer wellness products serving over 1 million monthly active users.

CORE TEAM

Daan Visser

Head of Growth & Partnerships

Growth lead with a strong network across EU clinics and insurers. Previously managed payer partnerships at a digital-therapeutics company operating in the Benelux region.

Core team

Lukas Smit

Lead Engineer & Infrastructure Architect

Backend and ML engineer focused on health-data pipelines and integrations. Built GDPR-compliant infrastructure connecting wearables and EHR systems at a prior medtech startup.

Strengths

The founding team blends clinical nutrition credibility with proven SaaS product and engineering delivery, backed by a respected practicing-clinician advisor who anchors regulatory and reimbursement strategy.

Gaps

No dedicated commercial or insurer-contracting lead has been hired yet, and clinical-affairs and regulatory capacity currently depend on the part-time advisor rather than a full-time in-house function.

Product

Product Score: 4 / 5

The platform pairs a consumer app with a clinician dashboard. Patients log meals via photo and connected devices; AI estimates macros and micronutrients, while care teams set goals, track adherence, and message securely. Integrates with wearables and EHRs.

Revenue Model

SaaS Subscription (clinics) + Freemium consumer app

Pricing

€29 per clinician seat per month, annual billing

Monetization Stage

Revenue generating, early traction

Product/Service

AI photo-based food logging that automatically estimates macros and micronutrients to cut patient data-entry burden
Clinician dashboard for dietitians to monitor adherence, set goals, and message patients securely in one place
Wearable and health-data integrations (Apple Health, Google Fit, glucose monitors) for a unified nutrition record
Personalized meal-planning engine with allergy, budget, and cultural dietary preference filters built in

Traction

Month over month active-user growth averaging 18% over six consecutive months since product launch
12 Dutch clinics and two regional health insurers running paid pilots covering roughly 3,000 patients
Selected for the Rockstart Health accelerator cohort with non-dilutive grant support secured

Roadmap

2026 Q3: Launch continuous glucose monitor (CGM) integration for diabetes and pre-diabetes cohorts
2026 Q4: Release multilingual clinician dashboard and expand pilots into Belgium and Germany

Market

Market Score: 5 / 5

TAM

€18 Bn (global digital nutrition & wellness)

SAM

€3.2 Bn (EU clinical nutrition & chronic-disease management)

SOM

€180 Mn (achievable EU clinic + insurer share within current GTM)

Target market

Dietitians, hospital nutrition departments, chronic-disease clinics, and health insurers across the EU managing patients with diabetes, obesity, and cardiovascular risk who need measurable, continuous adherence data.

Growth Drivers

Rising chronic-disease burden and a reimbursement shift toward preventive digital care are pushing payers and clinics to adopt tools that prove patient adherence and outcomes at scale.

Category

HealthTech / Digital Nutrition / Clinical Decision Support / Chronic Disease Management

Why now

Insurers and regulators increasingly reimburse digital therapeutics, and mainstream wearable and CGM adoption now supplies the continuous data needed to make nutrition care measurable and clinically credible.

Competitive Landscape

MyFitnessPal — strong consumer logging but no clinician dashboard or provider reimbursement pathway
Nutrium — dietitian-focused but limited AI logging and weak wearable and EHR integration
Oviva — closest clinical competitor, but a service-heavy model with higher cost and slower onboarding

Differentiation

AI photo-based logging reduces patient burden and improves adherence versus manual-entry competitors
Clinician and insurer reporting designed around EU reimbursement and GDPR data handling from day one
Open integration layer unifying wearables, CGMs, and EHRs into a single longitudinal nutrition record
Dual B2B/B2C model lets clinics onboard patients who then continue on a paid consumer tier

Market Risks

Reimbursement timelines vary by country and could slow insurer-led adoption beyond the Netherlands
The crowded consumer nutrition space could raise acquisition cost if B2C is pushed too early
Clinical-grade accuracy claims for AI logging will require ongoing validation and regulatory diligence

Deal

Deal Score: 4 / 5

Stage

Seed

Jurisdiction

Netherlands

Amount

€1,500,000

Instrument

Equity

Stake

15%

Valuation

€10,000,000

Investment Highlights

Strong founder-market fit pairing registered-dietitian expertise with proven product and engineering delivery
Genuine paid traction across 12 clinics and two insurers with healthy month-over-month user growth
Defensible integration and reimbursement positioning in a large, structurally growing EU market

Key Risks

The €10M valuation looks rich for seed stage relative to current ARR and early pilot revenue
Regulatory and clinical-validation overhead could extend runway needs beyond this round
Revenue is concentrated in early pilots; conversion to long-term paid contracts is still unproven

Investment Recommendation

Proceed to full due diligence. NutriTrack shows strong founder-market fit, real paid traction across clinics and insurers, and a defensible position in a large EU market. Before committing, negotiate the valuation toward a more typical seed range, confirm pilot-to-contract conversion rates, and independently validate the accuracy of the AI nutrient-estimation engine.

Disclaimer

This is not investment advice. The pre-scoring analysis is generated for informational purposes only and should not be relied upon as a basis for making investment decisions. Always conduct your own due diligence.